Recently, we found that BRG1 expression was markedly higher in patients with first-diagnosed B-ALL than in healthy individuals in the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) datasets. This evidence concerns the gene SMARCA4 and precursor B-cell acute lymphoblastic leukemia.